Xenter

About Xenter

Xenter, Inc. positions itself as a "Technology in Medicine" (TechMed) company, focused on developing a wireless ecosystem for healthcare. The company was founded in 2020 by Richard J. Linder, a seasoned entrepreneur in the life sciences sector with a history of founding and leading multiple medical device companies. The inspiration for Xenter stemmed from Linder's own battle with a life-threatening illness, which highlighted the need to merge modern technology with medical devices to improve patient outcomes. Headquartered in Draper, Utah, the privately held company has secured significant funding, including a $12M Series A round in May 2021 and a total of $32.7M raised as of January 2023.

Xenter's business model converges medical devices, data, and drug innovation. The company develops smart medical devices, such as guidewires and catheters, equipped with proprietary sensors and wireless technology for use in interventional cardiology, interventional radiology, and neurointerventional radiology. These devices collect what Xenter terms "Physical Intelligence™"—actionable, real-time physiologic data from within the patient's body. This data is then wirelessly transmitted via the XenFI™ network, which includes the XenFI-Hub™, a communications device for clinical settings like ambulatory surgical centers and hospitals. The information is aggregated and stored in XMD™, a HIPAA-compliant global healthcare cloud. By applying artificial intelligence and machine learning algorithms to this vast dataset, Xenter aims to provide new insights for physicians, enable novel therapeutic drug research, and ultimately allow patients to have more control over their health data. This approach targets healthcare professionals, provider organizations, and patients, with the goal of automating clinical workflows, reducing procedural complexity, and lowering healthcare costs.

The founder, Richard J. Linder, has an extensive background in the medical device industry, having co-founded Rubicon Medical (which was acquired by Boston Scientific) and founded CoNextions Medical. He is also the founder and Chairman Emeritus of BioUtah, the state's life sciences trade association, and holds over 100 patents for medical devices. This deep industry experience informs Xenter's strategy of replacing conventional medical instruments with intelligent, data-producing technologies. The company has assembled a multidisciplinary team of experts in fields ranging from silicon chip design and AI to medical science and pharmacology to execute this vision.